NCT01204476
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Paraganglioma
Explore clinical trials studying Paraganglioma. Study availability and eligibility vary by location and protocol.
41 public trials
16 recruiting studies
Paraganglioma trial results
Completed
Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
NCT00458952
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- New York Presbyterian Hospital-Weill Cornell Medical Center New York, United States
- Duke University Medical Center Durham, North Carolina, United States
- Rhode Island Hospital Providence, Rhode Island, United States
Completed
Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers
NCT00188019
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Européen Georges Pompidou Hospital Paris, France
NCT00339131
- Conditions
- Adenocarcinoma, Carcinoid, Carcinoid Tumor, +10 more
- Locations
-
Not specified
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
DOTATOC PET/CT for Imaging NET Patients
NCT03583528
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +66 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
Active, Not Recruiting
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
NCT03839498
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
Active, Not Recruiting
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
NCT03946527
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
- Cleveland Clinic Cleveland, Ohio, United States
Active, Not Recruiting
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
NCT04711135
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumors, Neoplasms, +7 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Centre Léon Berard Lyon, France
Active, Not Recruiting
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
NCT05142241
- Conditions
- Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, +8 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States